Granite Point Capital Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-54,822	Closed	-$340K	–	99
2019 Q2	$340K	Hold	54,822	–	–	0.02%	83
2019 Q1	$390K	Hold	54,822	–	–	0.04%	93
2018 Q4	$468K	Sell	54,822 -139,893	-72%	-$1.82M	0.09%	77
2018 Q3	$3.9M	Sell	194,715 -7,400	-4%	-$174K	0.26%	37
2018 Q2	$5.22M	Sell	202,115 -40,800	-17%	-$1.13M	0.47%	23
2018 Q1	$5.81M	Sell	242,915 -27,600	-10%	-$870K	0.56%	13
2017 Q4	$9.17M	Sell	270,515 -63,000	-19%	-$1.76M	0.9%	6
2017 Q3	$7.06M	Buy	333,515 +70,000	+27%	+$1.28M	1.49%	8
2017 Q2	$4.61M	Buy	263,515 +28,000	+12%	+$463K	1.14%	13
2017 Q1	$4.12M	Sell	235,515 -20,516	-8%	-$350K	1.23%	9
2016 Q4	$4.33M	Buy	256,031 +31,700	+14%	+$490K	3.45%	6
2016 Q3	$3.68M	Hold	224,331	–	–	1.44%	17
2016 Q2	$3.4M	Buy	+224,331	New	+$3.7M	1.46%	12
2015 Q4	$2.85M	Buy	100,631 +45,000	+81%	+$758K	0.43%	12
2015 Q3	$931K	Sell	55,631 -6,182	-10%	-$141K	0.64%	40
2015 Q2	$1.62M	Hold	61,813	–	–	0.47%	30
2015 Q1	$1.08M	Hold	61,813	–	–	0.39%	44
2014 Q4	$1.07M	Hold	61,813	–	–	0.5%	40
2014 Q3	$1.04M	Buy	+61,813	New	+$1.06M	0.52%	39

Other funds holding ADMS